CD30 in normal and neoplastic cells.

TitleCD30 in normal and neoplastic cells.
Publication TypeJournal Article
Year of Publication1999
AuthorsChiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G
JournalClin Immunol
Date Published1999 Feb
KeywordsAnimals, Biomarkers, Tumor, Gene Expression, Hodgkin Disease, Humans, Ki-1 Antigen, Lymphocyte Activation, Mice, Neoplasms, Reed-Sternberg Cells, Signal Transduction

In 1982 Stein and coworkers identified a new molecule, CD30 (Ki-1), which is expressed by Reed-Sternberg (RS) cells of Hodgkin's Disease (HD) (1). Although CD30 is not a specific RS cell marker, its characterization has assumed an important role not only in the differential diagnosis of HD, but also in the identification of a morphologically and clinically distinct type of large cell lymphoma, now designated as anaplastic large cell lymphoma (ALCL) (2). The cloning of human and murine CD30 and the utilization of genetically manipulated animal models have rapidly expanded our knowledge on its physiological role in lymphoid development and differentiation. The goal of this review is to present an overview of this rapidly evolving field and discuss the role of CD30 in normal and neoplastic lymphoid cells.

Alternate JournalClin Immunol
PubMed ID10080826
Grant ListCA-14462 / CA / NCI NIH HHS / United States
CA-64033 / CA / NCI NIH HHS / United States
Related Faculty: 
Giorgio Inghirami, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700